Cargando…
Stress Cardiomyopathy Precipitated by Withdrawal of Epoprostenol
We describe a case of stress-induced cardiomyopathy following epoprostenol withdrawal. A patient with pulmonary arterial hypertension presented with a malfunctioning Hickman catheter. Inappropriate withdrawal of epoprostenol resulted in shock. Evaluation confirmed stress-induced cardiomyopathy. Rest...
Autores principales: | Gionfriddo, William J., Ahmed, Hanna N., Farber, Harrison W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298301/ https://www.ncbi.nlm.nih.gov/pubmed/34317225 http://dx.doi.org/10.1016/j.jaccas.2019.10.040 |
Ejemplares similares
-
Epoprostenol‐associated ascites in pulmonary arterial hypertension
por: Schoenberg, Noah C., et al.
Publicado: (2022) -
Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
por: Calcaianu, George, et al.
Publicado: (2017) -
Epoprostenol: Exacerbation of thrombocytopenia : case report
Publicado: (2021) -
Alteplase/epoprostenol: Lack of efficacy: case report
Publicado: (2022) -
Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension
por: Abston, Eric, et al.
Publicado: (2020)